a year ago
SANA
AnalystsEmily BodnarEmily Bodnar's Stock Forecasts
AnalystsEmily Bodnar
Sectors:
Analyst Ranking
Bottom 3%
#5028 out of 5139 analysts
Average Return
-3.58%
Win Rate
29%92 out of 315
Risk vs Reward
Poor
Good
Emily Bodnar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Olema Pharmaceuticals IncOLMA | +546.72% | $4.11 | $26.58 | 2025-03-18 - 2025-12-09 | Buy |
Olema Pharmaceuticals IncOLMA | +523.94% | $4.26 | $26.58 | 2025-03-04 - 2025-12-09 | Buy |
Olema Pharmaceuticals IncOLMA | +513.86% | $4.33 | $26.58 | 2025-03-10 - 2025-12-09 | Buy |
Olema Pharmaceuticals IncOLMA | +443.56% | $4.89 | $26.58 | 2025-04-27 - 2025-12-09 | Buy |
Gracell Biotechnologies IncGRCL | +372.38% | $2.10 | $9.92 | 2023-02-15 - 2023-12-26 | Buy |
Emily Bodnar Analyst Color
Get additional color on Emily Bodnar's coverage of popular stocks
2 years ago
FEMY
Emily Bodnar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Acrivon Therapeutics IncACRV | 12 | Buy | $19.00 | +663.05% | Reiterates | 16 days ago |
Anaptysbio IncANAB | 12 | Buy | $51.00 | +16.44% | Maintains | 17 days ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $48.00 | +78.77% | Maintains | 21 days ago |
Olema Pharmaceuticals IncOLMA | 21 | Buy | $36.00 | +35.44% | Maintains | 22 days ago |
Artiva Biotherapeutics IncARTV | 2 | Buy | $15.00 | +380.77% | Maintains | a month ago |
Sana Biotechnology IncSANA | 11 | Buy | $9.00 | +106.90% | Maintains | a month ago |
Context Therapeutics IncCNTX | 11 | Buy | $5.00 | +380.77% | Maintains | a month ago |
Ventyx Biosciences IncVTYX | 14 | Buy | $18.00 | +111.52% | Upgrades | a month ago |
Novocure LtdNVCR | 19 | Buy | $42.00 | +230.71% | Maintains | a month ago |
Arcus Biosciences IncRCUS | 6 | Buy | $28.00 | +11.69% | Maintains | a month ago |
Rapt Therapeutics IncRAPT | 3 | Buy | $72.00 | +154.60% | Maintains | a month ago |
Senti Biosciences IncSNTI | 1 | Buy | $12.00 | +679.22% | Initiates Coverage On | 2 months ago |
Tg Therapeutics IncTGTX | 1 | Buy | $60.00 | +97.17% | Assumes | 2 months ago |
Agenus IncAGEN | 14 | Buy | $23.00 | +486.73% | Reiterates | 3 months ago |
Briacell Therapeutics CorpBCTX | 15 | Buy | $40.00 | +225.73% | Maintains | 3 months ago |
Mink Therapeutics IncINKT | 14 | Buy | $35.00 | +217.60% | Upgrades | 4 months ago |
Vtv Therapeutics IncVTVT | 2 | Buy | $36.00 | +11.59% | Reiterates | 4 months ago |
Femasys IncFEMY | 25 | Buy | $8.00 | +867.35% | Maintains | 4 months ago |
Sab Biotherapeutics IncSABS | 2 | Buy | $9.00 | +139.36% | Maintains | 5 months ago |
Jasper Therapeutics IncJSPR | 10 | Buy | $20.00 | +1,029.94% | Maintains | 5 months ago |
Nextcure IncNXTC | 9 | Buy | $36.00 | +223.16% | Reiterates | 5 months ago |
Arcellx IncACLX | 13 | Buy | $115.00 | +62.34% | Reiterates | 6 months ago |
Transcode Therapeutics IncRNAZ | 17 | Buy | $280.00 | +2,913.99% | Maintains | 8 months ago |
Connect Biopharma Holdings LtdCNTB | 6 | Buy | $8.00 | +236.13% | Reiterates | 8 months ago |
Io Biotech IncIOBT | 13 | Buy | $12.00 | +1,316.77% | Reiterates | 8 months ago |
Genelux CorpGNLX | 7 | Buy | $30.00 | +559.34% | Reiterates | 8 months ago |
Nkarta IncNKTX | 13 | Buy | $18.00 | +847.37% | Reiterates | 8 months ago |
Imunon IncIMNN | 13 | Buy | $210.00 | +5,189.67% | Reiterates | 8 months ago |
Atossa Therapeutics IncATOS | 13 | Buy | $7.00 | +765.27% | Reiterates | 8 months ago |
Tenaya Therapeutics IncTNYA | 1 | Buy | $18.00 | +1,176.60% | Reiterates | 10 months ago |
Acelyrin IncSLRN | 13 | Hold | $6.00 | +164.32% | Maintains | a year ago |
Geron CorpGERN | 3 | Buy | $9.00 | N/A | Reiterates | a year ago |
Purple Biotech LtdPPBT | 13 | Buy | $33.00 | N/A | Reiterates | a year ago |
Gracell Biotechnologies IncGRCL | 6 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 8 | Hold | $48.00 | N/A | Reiterates | 2 years ago |
Sqz Biotechnologies CoSQZB | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.